Third Harmonic Bio, Inc. (NASDAQ: THRD) Stock Information | RedChip

Third Harmonic Bio, Inc. (NASDAQ: THRD)


$14.0600
-0.1300 ( -0.92% ) 20.0K

Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.

Market Data


Open


$14.0600

Previous close


$14.1900

Volume


20.0K

Market cap


$579.89M

Day range


$13.8350 - $14.3050

52 week range


$5.7650 - $16.9400

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Mar 28, 2024
10-k Annual reports 83 Mar 26, 2024
8-k 8K-related 12 Mar 26, 2024
3 Insider transactions 2 Jan 09, 2024
4 Insider transactions 1 Jan 09, 2024
4 Insider transactions 1 Jan 09, 2024
4 Insider transactions 1 Jan 09, 2024
4 Insider transactions 1 Jan 09, 2024
4 Insider transactions 1 Jan 05, 2024
8-k 8K-related 32 Jan 04, 2024

Latest News